News-Medical.Net on MSN18h
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback